Zolgensma - direct healthcare professional communication (DHPC)

onasemnogene abeparvovec
DHPCHuman

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

Tietoja

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Asiakirjat

Direct healthcare professional communication (DHPC): Zolgensma (onasemnogene abeparvovec): risk for thrombotic microangiopathy

English (EN) (126.15 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Key facts

Medicine name
Zolgensma
Active substance
onasemnogene abeparvovec
Procedure number
EMEA/H/C/004750/II/0008
Regulatory outcome
Variation
DHPC type
Type II variation
Human ATC codes
M09AX09
Dissemination date

Share this page